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Severe acute respiratory syndrome coronavirus 2 viral 
load in the upper respiratory tract peaks around symp-
tom onset and infectious virus persists for 10 days in 
mild-to-moderate coronavirus disease (n = 324 sam-
ples analysed). RT-PCR cycle threshold (Ct) values 
correlate strongly with cultivable virus. Probability of 
culturing virus declines to 8% in samples with Ct > 35 
and to 6% 10 days after onset; it is similar in asymp-
tomatic and symptomatic persons. Asymptomatic per-
sons represent a source of transmissible virus.
Since the emergence of coronavirus disease (COVID-19) 
at the end of 2019, rapid tracing and isolation of con-
firmed cases and close contacts with restrictions on 
social movement have played an important role in con-
trolling onward spread of the virus. Understanding the 
duration of infectiousness in persons who test positive 
for severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) is critical to developing evidence-based 
public health policies on isolation, contact tracing and 
return to work. Virus detection by reverse transcrip-
tion-PCR (RT-PCR) from respiratory samples is widely 
used to diagnose and monitor SARS-CoV-2 infection 
and, increasingly, to infer infectivity of an individual. 
However, RT-PCR does not distinguish between infec-
tious and non-infectious virus. Propagating virus from 
clinical samples confirms the presence of infectious 
virus but is not widely available, requires biosafety 
level 3 facilities, and the results are not timely to 
inform public health actions. The aim of this work was 
to understand how RT-PCR detection relates to cultiva-
ble virus, which can be used as a proxy for infectious-
ness and can inform and support decisions on infection 
control.
 
Kinetics of viral RNA detection from the 
respiratory tract
Upper respiratory tract (URT) samples from persons 
with suspected COVID-19 were tested at the national 
respiratory virus reference laboratory at Public Health 
England to support routine clinical care and sur-
veillance activities during the COVID-19 pandemic. 
Samples included nose, throat, combined nose-and-
throat and nasopharyngeal swabs, or nasopharyngeal 
aspirates; the majority were taken by clinical staff but 
some were self-sampled nose swabs.
In the first 3 months of the COVID-19 pandemic in the 
United Kingdom (UK) (late January to early April 2020), 
we received 754 URT samples from 425 symptomatic 
cases that tested positive for SARS-CoV-2 by RT-PCR 
targeting the RNA-dependent RNA polymerase (RdRp) 
gene [1] and that had a clear record of the dates of 
symptom onset and sample collection. These samples 
were collected as part of the First Few 100 surveillance 
study described in Boddington et al. [2]. Using RT-PCR 
cycle threshold (Ct) values as a semiquantitative meas-
ure of SARS-CoV-2 viral load identified that the level 
of SARS-CoV-2 RNA in the URT was greatest around 
symptom onset, steadily decreased during the first 10 
days after illness onset and then plateaued (Figure 1). 
In the first week after symptom onset (days −2 to 7), 
geometric mean (GM) Ct was 28.18 (95% confidence 
interval (CI): 27.76–28.61). In the second week (days 8 
to 14), GM Ct was 30.65 (95% CI: 29.82–31.52; p < 0.001 
compared with week 1) and after 14 days, GM Ct was 
31.60 (95% CI: 31.60–34.49; p = 0.01 compared with 
week 1). There was no significant difference in Ct val-
ues between days 8–14 and after 14 days (p = 0.49).
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Isolation of infectious virus from 
respiratory samples
Virus culture was attempted from 324 URT samples 
(from 253 cases) that tested positive for SARS-CoV-2 by 
RT-PCR. Samples were obtained from a range of clinical 
scenarios including community and healthcare worker 
surveillance, symptomatic persons tested as part of the 
early epidemic response and samples acquired in out-
break investigations. Selection of asymptomatic cases 
was through swabbing of contacts or facility/family/
household testing in the context of outbreak investiga-
tions; we cannot be certain of their date of exposure 
or start of infection. Vero E6 cells were inoculated with 
clinical specimens and incubated at 37 °C, 5% CO2. 
Cells were inspected for cytopathic effect daily up to 14 
days. Presence of SARS-CoV-2 was confirmed by SARS-
CoV-2 nucleoprotein staining by enzyme immunoassay 
on infected cells. Cultivable virus was isolated from 
133 (41%) samples (from 111 cases).
Median Ct of all 324 samples was 31.15 (interquar-
tile range (IQR): 27.50–33.86; range: 17.47–41.78). 
Some 233 cases (92%) were classified as non-severe 
(asymptomatic or mild-to-moderate) and 20 (8%) had 
severe illness (requiring intensive care admission and/
or fatal). There was no difference in Ct values between 
those with asymptomatic (median Ct = 31.23; IQR: 
28.21–32.97), mild-to-moderate (median Ct = 30.94; 
IQR: 27.08–34.57) or severe (median Ct = 32.55; IQR 
28.39–33.66) illness (p = 0.79). A stratified comparison 
of the severe cases over time showed a similar result 
as described above: Ct values were lower (higher viral 
load) in week 1 than week 2. There were 62 samples 
from 61 asymptomatic cases and no difference in cul-
ture positivity rate was observed: 21 of 62 samples 
from asymptomatic individuals vs 112 of 262 samples 
from symptomatic individuals (estimated odds ratio 
(OR) = 0.66; 95% CI: 0.34–1.31; mixed effects logistic 
regression model, p = 0.23).
Relationship between Ct value and virus 
isolation
We observed a strong relationship between Ct value 
and ability to recover infectious virus. The estimated 
OR of recovering infectious virus decreased by 0.67 
for each unit increase in Ct value (95% CI: 0.58–0.77) 
(Figure 2). Virus propagation was successful from five 
of 60 samples with Ct > 35; all five were from symp-
tomatic cases and none had severe illness. The esti-
mated probability of recovery of virus from samples 
with Ct > 35 was 8.3% (95% CI: 2.8%–18.4%).
Relationship between ‘symptom to test’ 
interval and virus isolation
There were 246 samples from 176 symptomatic cases 
where the date of symptom onset was known, of 
which 103 (42%) samples from 81 cases were culture-
positive. Detection of cultivable virus peaked around 
the time of symptom onset (Figure 3). Median dura-
tion of virus shedding as measured by culture was 4 
days (IQR: 1–8; range: −13 to 12, with symptom onset 
dates based on symptom recall). The culture positiv-
ity rate was significantly higher during week 1 than 
week 2 (74% vs 20%; p = 0.002). Ten days after symp-
tom onset, the probability of culturing virus declined 
to 6.0% (95% CI: 0.9–31.2%) (Table 1). Where cases 
Figure 1
Detection of SARS-CoV-2 by RT-PCR targeting the RdRp 
gene, England, January–April 2020 (n = 754)
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To capture the nonlinear relationship between days post symptom 
onset (days) and Ct value, a fractional polynomial model was 
used, indicating predictors days2 and days2ln(days). These 
were fitted in a random intercept regression model with ln(Ct 
value) as the outcome variable. Analysis accounted for multiple 
samples from the same individuals. The random intercept 
for individuals was not statistically significant, providing no 
evidence for dependencies within person, thus each individual 
sample was treated as being independent.
Figure 2
Relationship between RT-PCR Ct value and culture 
positivity in mixed effects logistic regression analysis, 
SARS-CoV-2, England, January–May 2020 (n = 324)
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a Wide confidence intervals due to small sample size.
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were followed up within outbreak investigations, 13 
individuals who were asymptomatic at the time of sam-
pling developed symptoms within 14 days of sampling 
and were classified as presymptomatic, of whom seven 
were culture-positive. Regression analysis indicates 
that presymptomatic samples were at least as likely to 
be culture-positive as samples taken during sympto-
matic phases.
More than half the samples (n = 130, 53%) tested (from 
91 cases) were received more than 7 days after symp-
tom onset and 21% of those (27 samples from 18 
cases) were culture-positive; none of the 91 patients 
had severe illness or were immunosuppressed. Most of 
these late culture-positive samples (25/27) were taken 
between 8 and 10 days after symptom onset.
 
Comparison of virus detection by age group
There was no significant difference in Ct values 
(p = 0.12) or culture positivity (p = 0.63) from URT 
samples received across the different age groups, 
although this dataset included few children younger 
than 16 years. The proportion of asymptomatic cases 
was similar across age groups, except for 81–100 year-
olds who were more likely to be asymptomatic than the 
other age groups (p = 0.006, cluster-adjusted logistic 
regression) (Table 2). There was no difference in the 
proportion of asymptomatic cases between males and 
females, with an estimated OR of 0.86 (95% CI: 0.46–
1.90; p = 0.63).
Discussion
Readouts from semiquantitative RT-PCR using Ct values 
provide a valuable proxy for infectious virus detection 
and may help to inform decision-making on infec-
tion control. This study adds to the evidence base on 
duration of infectiousness following mild-to-moderate 
COVID-19, demonstrating that infectious virus can per-
sist for a week or more after symptom onset, declining 
over time. At 10 days after symptom onset, in line with 
current guidance from the World Health Organization 
[3] and the UK [4] on release from isolation, probability 
of culturing virus declines to 6%. The findings concur 
with smaller studies that identified infectious virus 
shed for 8 or 9 days [5-9] and others demonstrating 
correlation between Ct value/viral load and cultiva-
ble virus [5,9-11]. Strengths include the comparatively 
large size of this dataset, inclusion of a large propor-
tion (> 50%) of samples taken more than 7 days after 
symptom onset and that all analysis was performed in 
a single laboratory. Van Kampen et al. reported more 
prolonged detection of cultivable virus from 23 hospi-
talised cases, for up to 20 days after symptom onset 
[10]. However, their cohort included mostly lower res-
piratory tract samples from patients with more severe 
disease including nearly one in five who were immuno-
compromised, which is unlikely to be representative of 
the general population. Taken together with data pre-
sented here, the results of Van Kampen et al. indicate 
that more prolonged excretion of infectious virus could 
be associated with severe disease or an immunocom-
promised state.
This study identified that Ct values and the pres-
ence of infectious virus were similar in samples from 
asymptomatic and presymptomatic persons, compared 
with those who were symptomatic, and is one of the 
first reports of virus isolation from cases who remain 
completely asymptomatic. The findings suggest that 
asymptomatic and presymptomatic persons do rep-
resent a source of potentially transmissible virus. 
Extensive data on cultivable virus from asymptomatic 
or presymptomatic individuals are lacking, with one 
outbreak investigation in a care home reporting detec-
tion of cultivable virus in one asymptomatic and 17 
presymptomatic cases [8]. Although we saw a higher 
proportion of asymptomatic cases in the age group 
81–100 years, the reasons and significance of this are 
unclear. It may reflect sampling bias from care home 
outbreaks. However, it could also reflect real differ-
ences in response to infection in this age group (e.g. 
Figure 3
Relationship between culture positivity and time between 
symptom onset and sample collection, SARS-CoV-2, 
England, January–May 2020 (n = 246)
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lower response to fever, lower reporting of subjective 
symptoms in this age group).
Of note, recall bias may affect the interpretation of 
timing of virus detection in relation to symptom onset, 
particularly in elderly patients and those presenting 
with atypical symptoms. Duration and cessation of 
symptoms is also not well recorded. For asymptomatic 
cases, the time when infection was acquired is not 
known. A further limitation is that this dataset com-
prises real-world data and subjects were not sampled 
systematically; therefore, there may be bias in the tim-
ing of sampling related to the clinical scenario. Finally, 
the sensitivity of virus propagation from clinical sam-
ples is dependent on laboratory expertise, cell lines 
and protocols used, and may be affected by sample 
quality, storage and transport conditions, meaning it is 
difficult to directly compare data between laboratories 
described in other literature.
Conclusion
Based on the real-world data described here, we 
recommend that infection control measures for per-
sons with mild-to-moderate COVID-19 be particularly 
focussed immediately after onset of symptoms and 
retained for 10 days. Asymptomatic and presympto-
matic persons are likely to be a source of infectious 
virus. Detection of cultivable SARS-CoV-2 from URT 
samples is valuable as a proxy for infectiousness; how-
ever, as the human infectious dose remains unknown, 
the significance of low titres of infectious virus for 
human-to-human transmission remains uncertain. 
Correlation with observational epidemiological data 
analysing known infector–infectee pairs is required to 
fully understand the dynamics of infectiousness and 
viral transmissibility.
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Table 1
Estimated percentage of SARS-CoV-2 samples culture-positive 7–15 days after symptom onset, England, January–May 2020 
(n = 121)
Day post symptom onset Estimateda percentage culture-positive (95% CI) N (observed number tested) R (observed number culture-positive
7 40.1 (22.8–60.4) 14 10
8 25.8 (11.0–49.4) 33 9
9 13.7 (3.7–39.6) 34 10
10 6.0 (0.9–31.2) 23 6
11 2.2 (0.2–23.9) 6 1
12 0.7 (0.0–17.9) 3 1
13 0.2 (0.0–13.1) 4 0
14 0.03 (0.0–9.4) 2 0
15 0.006 (0.0–6.7) 2 0
CI: confidence interval.
a From mixed effects logistic regression model.
Table 2 
Comparison of virus detection and presence of symptoms, by age group, England, January–May 2020 (n = 324)
Age group in years Number of cases
Ct value Virus isolation Asymptomatic cases
Geometric mean 95% CI Estimated % culture-positive 95% CI % 95% CI
0–20 14 28.81 26.50–31.33 57.8 26.7–83.8 14.3 3.0–47.3
21–40 81 30.81 29.77–31.90 43.2 30.7–56.5 17.5 10.0–28.9
41–60 140 30.83 30.03–31.65 37.7a 27.8–48.7 13.6 8.6–20.8
61–80 40 29.87 28.42–31.38 41.3 24.4–60.5 17.5 7.8–34.6
81–100 49 29.09 27.84–30.41 32.1 18.8–49.2 40.8 27.4–55.7
CI: confidence interval; Ct: cycle threshold.
Estimated geometric mean Ct value, proportion culture-positive and proportion asymptomatic from random intercept linear, random intercept 
logistic regression and cluster adjusted logistic regression models.
a Total excluding one case because one sample was cytotoxic on cell culture.
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